Istituto Oncologico Veneto IRCCS ( Site 4355)

Padova 35128

0 studies enrolling now · 1 studies all time

What they study most

Melanoma

Studies at this site

• Substudy 02D: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Melanoma Brain Metastasis (MK-3475-02D/KEYMAKER-U02) — Completed